- ADVISE clinical trial initiated and enrollment progressing- Evaluating patients with the clinical diagnosis of moderate-to-severe atopic dermatitis - Significant unmet need for an oral therapy in atopic dermatitis SAN DIEGO, Oct. 28, 2019 /PRNewswire/ -- 

PLYMOUTH MEETING, Pa., Oct. 28, 2019 /PRNewswire/ -- The National Comprehensive Cancer Network (NCCN®) Oncology Research Program (

NEW YORK, Oct. 28, 2019 /PRNewswire/ -- Actinium Pharmaceuticals, Inc.  (NYSE AMERICAN: ATNM) ("Actinium") today announced key interim findings from the pivotal Phase 3 SIERRA trial of Iomab-B, including feasibility and safety data, at 50% of total patient enrollment. The SIERRA trial (Study of Iomab-B in E

FORT LAUDERDALE, Fla., Oct. 28, 2019 /PRNewswire/ -- CarePredict, the leading AI-powered preventive senior care platform announced today the launch of the third generation

BOZEMAN, Mont. and VANCOUVER, British Columbia, Oct. 28, 2019 /PRNewswire/ -- Microbion Corporation of Bozeman, MT, and Microbion Pharma Corp. of Vancouver, BC ("Microbion") today announced results from a Phase 1b trial of its novel microb

NEW YORK, Oct. 28, 2019 /PRNewswire/ -- Nuvation Bio, Inc., a stealth biotechnology company developing proprietary therapies focused on oncology, announces the closing of $275 million in an oversubscribed Series A financing. The round was led, structured and syndicated by Omega Funds and included participation from leading biotechnology inve

CAMBRIDGE, Mass., Oct. 28, 2019 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced an update regarding its New Drug Application (NDA) for avapritinib for the treatment of adults with PDGFRA Exon 18 mutant GIST, regardless of prior

SAN DIEGO, Oct. 28, 2019 /PRNewswire/ -- Viracta Therapeutics, Inc., a precision oncology company targeting virus-associated malignancies, today announced the closing of a Series D Preferred St

LOS ANGELES, Oct. 28, 2019 /PRNewswire/ -- Theragun, Inc., the leader in hand-held percussive therapy devices, has entered into a comprehensive partnership with Life Time, the nation's premier healthy l

FORT WORTH, Texas, Oct. 28, 2019 /PRNewswire/ -- Le-Vel, the world leader in human nutritional and skincare innovation, debuted its new product, THRIVE Sculpt, an amino acid capsule formulated to help the body build lean muscle, burn fat, increase stamina, and lose inches in combination with a healthy diet and exercise. THRIVE Sculpt is the first ever product releas